AMRUTA SHANBHAG: Open Payments
NPI 1295297083 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 11 payments from 8 companies in 2025. Trend: 2023 $46 · 2024 $85 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| Biogen, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: ABILIFY MAINTENA, SPRAVATO, ZURZUVAE, VRAYLAR, UZEDY, REXULTI, CAPLYTA, LOREEV XR.
Industry payments across CA — which companies pay providers there.
